Sugammadex shortage — IT supply status & alternatives

Sugammadex

—

🇦🇺 AUST R 331085 · Dr Reddys Laboratories Australia Pty Ltd

In supply · Australia

Bridion

In supply · 🇦🇺 Australia · short in🇮🇹 IT🇬🇷 GR🇳🇱 NL

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Sugammadex
Brand names	Bridion
Therapeutic category	Auto-created by CBG-MEB (Netherlands) scraper

Controlled substance	No

Marketing-authorisation holders	Dr Reddys Laboratories Australia Pty Ltd, Accord Healthcare Pty Ltd, Alphapharm Pty Ltd, Sandoz Pty Ltd +4 more

Registrations on file	30

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

28 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Yangtze River Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical CO LTDApitoria Pharma Private LTDMatrix Pharmacorp Private LTDDr Reddys Laboratories LTDMsn Life Sciences Private LTDNeuland Laboratories LTD+22 more

Manufacturing countries: China, India, Malta, Israel, Spain · Source: FDA List of Drug Master Files

Verified timeline regulator events

🇮🇹 31 Mar 2027

Shortage resolved

🇮🇹 1 June 2026

critical reported

🇬🇷 22 May 2026

medium reported

🇳🇱 23 Mar 2026

medium reported

🇮🇹 18 Aug 2025

Shortage resolved

🇮🇹 1 May 2025

critical reported

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders30 registrations · 8 MA holders

Product	Strength	Form	Market	MA holder	Status
Reddy'S	500 mg	—	🇦🇺 AU	Dr Reddys Laboratories Australia Pty Ltd	Active
Reddy'S	200 mg	—	🇦🇺 AU	Dr Reddys Laboratories Australia Pty Ltd	Active
Rz	500 mg	—	🇦🇺 AU	Dr Reddys Laboratories Australia Pty Ltd	Active
Dr Reddy'S	200 mg	—	🇦🇺 AU	Dr Reddys Laboratories Australia Pty Ltd	Active
Dr Reddy'S	500 mg	—	🇦🇺 AU	Dr Reddys Laboratories Australia Pty Ltd	Active
Arx	200 mg	—	🇦🇺 AU	—	Active
Arx	500 mg	—	🇦🇺 AU	—	Active
Accord	500 mg	—	🇦🇺 AU	Accord Healthcare Pty Ltd	Active
Viatris	200 mg	—	🇦🇺 AU	Alphapharm Pty Ltd	Active
Viatris	500 mg	—	🇦🇺 AU	Alphapharm Pty Ltd	Active
Sandoz	200 mg	—	🇦🇺 AU	Sandoz Pty Ltd	Active
Sandoz	500 mg	—	🇦🇺 AU	Sandoz Pty Ltd	Active
Medicianz	500 mg	—	🇦🇺 AU	Medicianz Healthcare Pty Ltd	Active
Accord	200 mg	—	🇦🇺 AU	Accord Healthcare Pty Ltd	Active
Medicianz	200 mg	—	🇦🇺 AU	Medicianz Healthcare Pty Ltd	Active

+15 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.